Study questions the need for endotype-specific diets in diabetes management

Study finds minor differences in dietary adherence and its impact on cardiovascular and kidney outcomes across diabetes endotypes, indicating limited evidence for endotype-specific dietary guidelines.

SYNLAB delivers robust performance in FY 2023 – Biotech Investments

EQS-News: SYNLAB AG / Key word(s): Annual Results SYNLAB delivers robust performance in FY 2023 25.03.2024 / 07:00 CET/CEST The issuer is solely responsible for

March 26, 2024

PRO-1107 by ProfoundBio Suzhou for Solid Tumor: Likelihood of Approval – Pharmaceutical Technology

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 20, 2024

UVA research reveals nervous system’s role in C. difficile infections

The portion of our nervous systems responsible for the “fight or flight” response can shape the severity of potentially deadly C. difficile infections, new research

October 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.